Contineum Therapeutics, Inc. Class A (CTNM) Dividend History

Contineum Therapeutics, Inc. Class A (CTNM) is a biopharmaceutical company focused on developing innovative therapies for rare and serious diseases. The company is dedicated to advancing novel treatment options through cutting-edge research and collaboration, aiming to improve patient outcomes and address unmet medical needs.

10578 Science Center Drive, Suite 200, San Diego, CA, 92121
Phone: (858) 333-5280
Website:

Dividend History

Contineum Therapeutics, Inc. Class A currently does not pay dividends

Company News

  • The pulmonary fibrosis market is driven by the increasing prevalence of the disease, especially idiopathic pulmonary fibrosis, among the aging population. Innovations in drug development and diagnostics, favorable reimbursement policies, and greater awareness are fueling market growth. The pipeline appears robust with over 110 active players working on 120+ pipeline drugs.

    GlobeNewswire Inc.
    Featured Companies: SNDX SRPT TRVI
  • RAPT Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Lori Lyons-Williams as the new chair of its board of directors, succeeding William Rieflin. Lyons-Williams is an industry veteran with over 20 years of experience in the pharmaceutical and biotech sectors.

    GlobeNewswire Inc.
    Featured Companies: RAPT
  • This article discusses the upcoming events in the financial world, including the Federal Reserve meeting, corporate earnings, IPOs, and investor events.

    Seeking Alpha
  • Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 million versus expectations of $141.897 million. Skillsoft shares dipped 26.7% to $6.74 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers WiSA Technologies, Inc. (NASDAQ: WISA) jumped 85% to $3.2379 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand. Palisade Bio, Inc. (NASDAQ: PALI) shares climbed 79.1% to $7.45 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108. Jaguar Health, Inc. (NASDAQ: JAGX) shares gained 67% to $0.1989 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair. Dynatronics Corporation (NASDAQ: DYNT) shares rose 44.4% to $0.5342 after dipping over 5% on Monday. IMAC Holdings, Inc. (NASDAQ: BACK) surged 40% to $4.69. Peraso Inc. (NASDAQ: PRSO) gained 38.8% to $1.75. Peraso recently announced that it received an additional $2.88 million purchase order. Macatawa Bank Corporation (NASDAQ: MCBC) rose 38.8% to $13.78 after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 29.9% to ...

    Benzinga
  • U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. Shares of UnitedHealth Group Incorporated (NYSE: UNH) rose sharply during Tuesday’s session following better-than-expected first-quarter earnings. The company reported adjusted EPS of $6.91, up from $6.26 a year ago, beating the consensus of $6.62. UnitedHealth’s revenues increased nearly $8 billion to $99.8 billion, beating the consensus of $99.3 billion, according to data from Benzinga Pro. UnitedHealth Group shares surged 6.2% to $473.20 on Tuesday. Here are some other big stocks recording losses in today’s session. Macatawa Bank Corporation (NASDAQ: MCBC) ...

    Benzinga
    Featured Companies: ALHC CGEM GB KEN NN SMCI UNH
Dividend data last updated 06/07/2025 17:51:25 UTC